Literature DB >> 9214660

Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities.

S Rauscher1, C Flamm, C W Mandl, F X Heinz, P F Stadler.   

Abstract

The prediction of the complete matrix of base pairing probabilities was applied to the 3' noncoding region (NCR) of flavivirus genomes. This approach identifies not only well-defined secondary structure elements, but also regions of high structural flexibility. Flaviviruses, many of which are important human pathogens, have a common genomic organization, but exhibit a significant degree of RNA sequence diversity in the functionally important 3'-NCR. We demonstrate the presence of secondary structures shared by all flaviviruses, as well as structural features that are characteristic for groups of viruses within the genus reflecting the established classification scheme. The significance of most of the predicted structures is corroborated by compensatory mutations. The availability of infectious clones for several flaviviruses will allow the assessment of these structural elements in processes of the viral life cycle, such as replication and assembly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214660      PMCID: PMC1369524     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  36 in total

1.  Sequence comparison and secondary structure analysis of the 3' noncoding region of flavivirus genomes reveals multiple pseudoknots.

Authors:  R C Olsthoorn; J F Bol
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

2.  Essential role of cyclization sequences in flavivirus RNA replication.

Authors:  A A Khromykh; H Meka; K J Guyatt; E G Westaway
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.

Authors:  T S Gritsun; T V Frolova; A I Zhankov; M Armesto; S L Turner; M P Frolova; V V Pogodina; V A Lashkevich; E A Gould
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region.

Authors:  John-Paul Mutebi; René C A Rijnbrand; Heiman Wang; Kate D Ryman; Eryu Wang; Lynda D Fulop; Rick Titball; Alan D T Barrett
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Long-range RNA-RNA interactions circularize the dengue virus genome.

Authors:  Diego E Alvarez; María F Lodeiro; Silvio J Ludueña; Lía I Pietrasanta; Andrea V Gamarnik
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses.

Authors:  Regina M Kofler; Verena M Hoenninger; Caroline Thurner; Christian W Mandl
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  A 5' RNA element promotes dengue virus RNA synthesis on a circular genome.

Authors:  Claudia V Filomatori; Maria F Lodeiro; Diego E Alvarez; Marcelo M Samsa; Lía Pietrasanta; Andrea V Gamarnik
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

8.  Automatic detection of conserved RNA structure elements in complete RNA virus genomes.

Authors:  I L Hofacker; M Fekete; C Flamm; M A Huynen; S Rauscher; P E Stolorz; P F Stadler
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

9.  A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication.

Authors:  Byung-Hak Song; Sang-Im Yun; Yu-Jeong Choi; Jeong-Min Kim; Chan-Hee Lee; Young-Min Lee
Journal:  RNA       Date:  2008-07-30       Impact factor: 4.942

Review 10.  Cis-acting RNA elements in human and animal plus-strand RNA viruses.

Authors:  Ying Liu; Eckard Wimmer; Aniko V Paul
Journal:  Biochim Biophys Acta       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.